These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones. Rammes G; Swandulla D; Spielmanns P; Parsons CG Neuropharmacology; 1998; 37(10-11):1299-320. PubMed ID: 9849667 [TBL] [Abstract][Full Text] [Related]
3. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. Rammes G; Swandulla D; Collingridge GL; Hartmann S; Parsons CG Br J Pharmacol; 1996 Mar; 117(6):1209-21. PubMed ID: 8882618 [TBL] [Abstract][Full Text] [Related]
4. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines. Donevan SD; Rogawski MA Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228 [TBL] [Abstract][Full Text] [Related]
10. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466. Kessler M; Arai A; Quan A; Lynch G Mol Pharmacol; 1996 Jan; 49(1):123-31. PubMed ID: 8569697 [TBL] [Abstract][Full Text] [Related]
12. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons. Liljequist S; Cebers G; Kalda A Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854 [TBL] [Abstract][Full Text] [Related]
13. Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus. Rammes G; Parsons C; Müller W; Swandulla D Neurosci Lett; 1994 Jul; 175(1-2):21-4. PubMed ID: 7970204 [TBL] [Abstract][Full Text] [Related]
14. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Arai AC; Kessler M; Rogers G; Lynch G Mol Pharmacol; 2000 Oct; 58(4):802-13. PubMed ID: 10999951 [TBL] [Abstract][Full Text] [Related]
15. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures. Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496 [TBL] [Abstract][Full Text] [Related]
16. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655. Partin KM; Mayer ML Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699 [TBL] [Abstract][Full Text] [Related]
17. Cyclothiazide unmasks an AMPA-evoked release of arachidonic acid from cultured striatal neurones. Williams RJ; Glowinski J J Neurochem; 1996 Oct; 67(4):1551-8. PubMed ID: 8858939 [TBL] [Abstract][Full Text] [Related]
18. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures. May PC; Robison PM; Fuson KS Neurosci Lett; 1999 Mar; 262(3):219-21. PubMed ID: 10218895 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by cyclothiazide of neuronal nicotinic responses in bovine chromaffin cells. Nooney JM; Feltz A Br J Pharmacol; 1995 Feb; 114(3):648-55. PubMed ID: 7735691 [TBL] [Abstract][Full Text] [Related]
20. Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices. Cowen MS; Beart PM Br J Pharmacol; 1998 Feb; 123(3):473-80. PubMed ID: 9504388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]